» Articles » PMID: 34180726

Barriers Experienced by Organ Procurement Organizations in Implementing the HOPE Act and HIV-positive Organ Donation

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2021 Jun 28
PMID 34180726
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In the seven years since the HIV Organ Policy Equity (HOPE) Act made HIV-positive organ donation to HIV-positive recipients legally permissible in the United States, there have been fewer HIV-positive organ donations than expected. Organ procurement organizations (OPOs) play a key role in the transplant system and barriers at OPOs may be partly responsible for the relatively low number of HIV-positive donors. To understand potential OPO barriers, we conducted semi-structured interviews with 20 OPO staff members. Interviews were recorded, transcribed, and analyzed using a conventional content analytic approach with two coders. OPO staff had high levels of knowledge about HOPE. Many had evaluated referrals of HIV-positive donors and approached families for authorization. Barriers to HIV-positive organ recovery identified included obtaining authorization for donation, potentially disclosing HIV status to next-of-kin, and fear of HIV infection among those engaged in organ recovery. Strategies to overcome these barriers include providing continuing education about the specific tasks required to procure organs from HIV-positive donors, implementing targeted interventions to reduce fear of infection, and developing partnerships with HIV advocacy and care organizations. Given the central role OPOs play, HIV-positive donations are unlikely to occur in significant numbers unless these barriers can be overcome.

Citing Articles

Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV.

Storm K, Durand C Clin Microbiol Rev. 2024; 37(1):e0011122.

PMID: 38240603 PMC: 10938893. DOI: 10.1128/cmr.00111-22.


Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium.

Durand C, Martinez N, Neumann K, Benedict R, Baker A, Wolfe C Lancet Reg Health Am. 2023; 24:100553.

PMID: 37600163 PMC: 10435840. DOI: 10.1016/j.lana.2023.100553.


Racial Disparities in Access to the Kidney Transplant Waitlist Among People with Human Immunodeficiency Virus.

Shelton B, Becker D, Maclennan P, Sen B, Budhwani H, Locke J AIDS Patient Care STDS. 2023; 37(8):394-402.

PMID: 37566535 PMC: 10457613. DOI: 10.1089/apc.2023.0037.


Efficacy of hope: Analysis of organ quality and availability among deceased HIV-positive donors.

Woods C, Owens G, Shelton B, Maclennan P, Sawinski D, Jacobson J Transpl Infect Dis. 2022; 24(6):e13916.

PMID: 35904220 PMC: 9780158. DOI: 10.1111/tid.13916.


Science Over Stigma: Lessons and Future Direction of HIV-to-HIV Transplantation.

Klitenic S, Levan M, Van Pilsum Rasmussen S, Durand C Curr Transplant Rep. 2021; 8(4):314-323.

PMID: 34812403 PMC: 8600909. DOI: 10.1007/s40472-021-00345-y.


References
1.
Sawinski D, Forde K, Locke J, Cohen J, Weldon J, Shults J . Race but not Hepatitis C co-infection affects survival of HIV individuals on dialysis in contemporary practice. Kidney Int. 2017; 93(3):706-715. DOI: 10.1016/j.kint.2017.08.015. View

2.
Bozkurt B, Kilic M . Marginal Donors in Renal Transplantation. Transplant Proc. 2015; 47(5):1273-81. DOI: 10.1016/j.transproceed.2015.04.006. View

3.
Hsieh H, Shannon S . Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):1277-88. DOI: 10.1177/1049732305276687. View

4.
Evans R, Orians C, Ascher N . The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA. 1992; 267(2):239-46. View

5.
Doby B, Tobian A, Segev D, Durand C . Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma. Curr Opin Organ Transplant. 2018; 23(2):271-278. PMC: 6110383. DOI: 10.1097/MOT.0000000000000510. View